Health charity Skin Check Champions, the University of South Australia, and the Hospital Research Foundation have teamed up to launch a pop-up clinic that uses AI to diagnose skin cancer.
Their pop-up clinics are led by nurses who take high-quality images of lesions from patients, which are then triaged and conditionally assessed by AI algorithms to determine whether they are cancerous. are victims of Results are also verified by local GPs.
The pop-up clinic was piloted during the 2023 Tour Down Under. Road cycling race in Victor Harbor early Saturday.
Why is this important?
During their lifetime, two out of three Australians will develop some form of skin cancer and more than 15,000 Australians have been diagnosed with melanoma, the most aggressive form of skin cancer and the highest in the country. It is the third most commonly diagnosed cancer. According to the Australian Institute of Health and Welfare, the disease costs the Australian health system about A$400 million ($280 million) each year.
Despite this fact, skin cancer prevention programs are “underfunded and under-resourced, especially outside the big cities,” notes Marion Eckert, professor of cancer nursing at UniSA. It was observed that the rate of skin cancer in regional areas was 31% higher than in metropolitan areas.
Professor Eckert added that more than 98 percent of skin cancer cases can be prevented if detected early. This is why SkinCheck Champions and its partners launched the Pop-Up Clinic project.
Scott Maggs, CEO of SkinCheck Champions, said, “Our goal is to halve the number of Australians who die from melanoma and increase the uptake of skin checks in Australia by 25% with AI-supported national skin checks. run the program.”
People living in regional areas can access skin screening services through their pop-up clinics, which will be at local community events such as the Tour Down Under.
There are some AI technologies available in the market that claim to accurately detect skin cancer. Just last year, a dermatology AI company Skin analytics Get its machine learning-based device DERM approved by medical device regulators in the UK. In 2021, ASX-listed Advanced human imaging It received the CE mark for its smartphone-based DermaScan AI technology, which can also screen for all types of skin cancer.
Meanwhile, there is another smartphone-based app from Denmark that uses AR technology to check the size of suspicious lesions or moles. gave Poor The app helps in self-examination of lesions suspected to be melanoma.
#AIpowered #popup #clinic #launched #South #Australia #detect #skin #cancer